These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 12925138)
61. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa]. Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675 [TBL] [Abstract][Full Text] [Related]
62. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF Cancer Lett; 2015 Apr; 359(2):345-51. PubMed ID: 25853150 [TBL] [Abstract][Full Text] [Related]
63. 4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils. Cao X; Tsukamoto T; Seki T; Tanaka H; Morimura S; Cao L; Mizoshita T; Ban H; Toyoda T; Maeda H; Tatematsu M Int J Cancer; 2008 Apr; 122(7):1445-54. PubMed ID: 18059022 [TBL] [Abstract][Full Text] [Related]
64. Atrophy, acid suppression and Helicobacter pylori infection: a tale of two studies. Genta RM Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S29-33; discussion S43-5. PubMed ID: 10503820 [TBL] [Abstract][Full Text] [Related]
65. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Matsumoto Y; Blanchard TG; Drakes ML; Basu M; Redline RW; Levine AD; Czinn SJ Helicobacter; 2005 Oct; 10(5):407-15. PubMed ID: 16181351 [TBL] [Abstract][Full Text] [Related]
66. Gastric mucosal cytokine and epithelial cell responses to Helicobacter pylori infection in Mongolian gerbils. Crabtree JE; Court M; Aboshkiwa MA; Jeremy AH; Dixon MF; Robinson PA J Pathol; 2004 Feb; 202(2):197-207. PubMed ID: 14743502 [TBL] [Abstract][Full Text] [Related]
67. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling. Su T; Li F; Guan J; Liu L; Huang P; Wang Y; Qi X; Liu Z; Lu L; Wang D Phytomedicine; 2019 Oct; 63():152968. PubMed ID: 31280140 [TBL] [Abstract][Full Text] [Related]
68. [Protective effects of sucralfate on gastric mucosal injury induced by Liu Y; Teng GG; Wang WH; Wu T; Hu FL Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1546-1552. PubMed ID: 31154720 [No Abstract] [Full Text] [Related]
69. Expression of nuclear factor-kappaB in Helicobacter pylori-infected gastric mucosa detected with southwestern histochemistry. Isomoto H; Miyazaki M; Mizuta Y; Takeshima F; Murase K; Inoue K; Yamasaki K; Murata I; Koji T; Kohno S Scand J Gastroenterol; 2000 Mar; 35(3):247-54. PubMed ID: 10766316 [TBL] [Abstract][Full Text] [Related]
70. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells. Kim CD; Kim HH; Hong KW J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763 [TBL] [Abstract][Full Text] [Related]
71. [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. Keto Y; Ebata M; Okabe S Nihon Yakurigaku Zasshi; 2001 Oct; 118(4):259-68. PubMed ID: 11680169 [TBL] [Abstract][Full Text] [Related]
72. The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome. Ng GZ; Menheniott TR; Every AL; Stent A; Judd LM; Chionh YT; Dhar P; Komen JC; Giraud AS; Wang TC; McGuckin MA; Sutton P Gut; 2016 Jul; 65(7):1087-99. PubMed ID: 26079943 [TBL] [Abstract][Full Text] [Related]
73. Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide. Matysiak-Budnik T; Thomas-Collignon A; Mégraud F; Heyman M Dig Dis Sci; 2001 Jul; 46(7):1558-66. PubMed ID: 11478510 [TBL] [Abstract][Full Text] [Related]
74. Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis. Hoshi T; Sasano H; Kato K; Ohara S; Shimosegawa T; Toyota T; Nagura H Hum Pathol; 1999 Dec; 30(12):1412-7. PubMed ID: 10667417 [TBL] [Abstract][Full Text] [Related]
75. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043 [TBL] [Abstract][Full Text] [Related]
76. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020 [TBL] [Abstract][Full Text] [Related]
77. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients. Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N World J Gastroenterol; 2005 Feb; 11(7):976-81. PubMed ID: 15742399 [TBL] [Abstract][Full Text] [Related]
78. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220 [TBL] [Abstract][Full Text] [Related]
79. [Importance of Helicobacter pylori in the pathogenesis of gastric cancer. Experimental models in rodents]. Barreto-Zúñiga R; Kato Y; Bobadilla DJ; Okuyama M; Maruyama M; Ohta H; Takekoshi T; Shigematsu A Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):25-33. PubMed ID: 11464619 [TBL] [Abstract][Full Text] [Related]